These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7496191)

  • 1. [Acute Trypanosoma brucei gambiense meningoencephalitis detected by papillary edema].
    Zola JM; Wassoumbou-Loubienga S; Goma GC; Mouanga-Yidika G
    Bull Soc Pathol Exot; 1994; 87(5):312-4. PubMed ID: 7496191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital human African trypanosomiasis: an observation at the University Hospital of Brazzaville (Congo)].
    Oba A; Gahtse A; Ekouya Bowassa G; Nika E; Obengui
    Arch Pediatr; 2011 Oct; 18(10):1114-5. PubMed ID: 21873039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging].
    Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F
    Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
    Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
    Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
    Hamon JF; Camara P
    Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eflornithine for African sleeping sickness.
    Sjoerdsma A; Schechter PJ
    Lancet; 1999 Jul; 354(9174):254. PubMed ID: 10421331
    [No Abstract]   [Full Text] [Related]  

  • 15. Winterbottom's sign and hypertrophic cardiomyopathy.
    Stephan C; Just-Nuebling G; Fichtlscherer S; Kriener S; Brodt HR
    Scand J Infect Dis; 2002; 34(7):544-5. PubMed ID: 12195887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise and fall of sleeping sickness.
    Barrett MP
    Lancet; 2006 Apr; 367(9520):1377-8. PubMed ID: 16650633
    [No Abstract]   [Full Text] [Related]  

  • 18. [The sleep-wake cycle during Trypanosoma brucei rhodesiense human African trypanosomiasis in 2 French parachutists].
    Montmayeur A; Brosset C; Imbert P; Buguet A
    Bull Soc Pathol Exot; 1994; 87(5):368-71. PubMed ID: 7496202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China.
    Chen N; Jin K; Xu J; Zhang J; Weng Y
    Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
    De Groof D; Bruneel H; Musumari TS; Ruppol JF
    Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.